Treatment Patterns and Clinical Outcomes in Youth with Comorbid ADHD and PTSD: Insights from Real-World Data
Journal of Attention Disorders · 2026
DOI: 10.1177/10870547261416173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, 2026. Verfasst von Raman Baweja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Penn State College of Medicine, Hershey, PA, USA. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Attention Deficit Disorder with Hyperactivity, Practice Patterns, Physicians'. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: national center for advancing translational sciences.
Abstract (Originalsprache)
Objectives
Attention-deficit/hyperactivity disorder (ADHD) and post-traumatic stress disorder (PTSD) often co-occur in youth, complicating the clinical presentation. However, little is known about how PTSD influences treatment selection or outcomes in youth with ADHD. This study examined prescribing patterns and clinical outcomes among youth with ADHD, with and without comorbid PTSD.
Methods
This retrospective cohort study used electronic health record data from the TriNetX Research Network, including over 714,000 youth (ages 6–18) diagnosed with ADHD (F90), of whom 30,341 (4.25%) also had comorbid PTSD (F43.1). Outcomes included treatment trends, emergency visits, hospitalizations, and subsequent antipsychotic or mood stabilizer prescriptions. Relative risks (RR), hazard ratios (HR), and 95% confidence intervals were calculated using propensity score matching and Cox proportional hazards models adjusted for sociodemographic and psychiatric variables.
Results
Among youth with ADHD, those with comorbid PTSD were older, had more psychiatric comorbidities, and were more likely to receive non-stimulants ( RR 1.54, 95% CI [1.51, 1.57]), antidepressants, antipsychotics, mood stabilizers (RRs 1.29–1.70), and psychotherapy ( RR 1.55, 95% CI [1.51, 1.60]). Methylphenidate prescriptions were slightly lower ( RR 0.97, 95% CI [0.95, 0.99]), while amphetamine use remained stable. Among youth with ADHD and PTSD, CNS stimulants were associated with the most favorable outcomes across all clinical measures, including hospitalizations, emergency visits, and subsequent antipsychotic and mood stabilizer use (aHRs 0.52–0.74), compared with non-stimulants and antidepressants.
Conclusions
Youth with ADHD and PTSD are clinically complex and receive broader treatment interventions. Clinicians appear to de-prioritize stimulants after PTSD diagnosis, despite evidence of superior clinical outcomes. Findings underscore the need for prospective studies and evidence-based treatment guidelines for this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Penn State College of Medicine, Hershey, PA, USA.
- Duke University School of Medicine, Dunham, NC, USA.
ORCID-Profile: Raman Baweja, Daniel A Waschbusch
Förderung
- national center for advancing translational sciences
Zitieren
APA
Baweja, R., Lopes, F., Padilla, F. M., Baweja, R., Amaya-Jackson, L., Waschbusch, D. A., & Waxmonsky, J. G. (2026). Treatment Patterns and Clinical Outcomes in Youth with Comorbid ADHD and PTSD: Insights from Real-World Data. Journal of Attention Disorders. https://doi.org/10.1177/10870547261416173
Vancouver
Baweja R, Lopes F, Padilla FM, Baweja R, Amaya-Jackson L, Waschbusch DA, et al. Treatment Patterns and Clinical Outcomes in Youth with Comorbid ADHD and PTSD: Insights from Real-World Data. Journal of Attention Disorders. 2026. doi:10.1177/10870547261416173
BibTeX
@article{Baweja2026,
author = {Baweja, Raman and Lopes, Fabiana and Padilla, Felix M and Baweja, Ritika and Amaya-Jackson, Lisa and Waschbusch, Daniel A and Waxmonsky, James G},
title = {Treatment Patterns and Clinical Outcomes in Youth with Comorbid ADHD and PTSD: Insights from Real-World Data},
journal = {Journal of Attention Disorders},
year = {2026},
doi = {10.1177/10870547261416173}
}
EUVIMED